Literature DB >> 18632834

The Chinese coronary artery bypass grafting registry study: analysis of the national multicentre database of 9248 patients.

Y Li1, Z Zheng, S Hu.   

Abstract

The past decade in China has heralded a rapid increase in surgical coronary revascularisation, and coronary artery bypass grafting (CABG) has now been possible in an increasingly high-risk population in China. However, little is known about the current status of CABG surgery in contemporary China. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) was introduced to China for risk adjustment in 2000 due to the absence of a local risk prediction model. Now, it is the most widely used risk prediction algorithm in China. Fuwai Hospital, Beijing, China has developed a national multicentre database of CABG patients, named the Chinese CABG Registry Study. We embarked on this study with a view to establishing risk stratification and outcome assessment following CABG in Chinese adults as well as to provide a potential clinical research tool for the future. The database will then serve to validate the widely used EuroSCORE model in Chinese patients and to develop a risk prediction model for Chinese patients undergoing CABG.

Entities:  

Mesh:

Year:  2008        PMID: 18632834     DOI: 10.1136/hrt.2008.146563

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  8 in total

1.  SinoSCORE: a logistically derived additive prediction model for post-coronary artery bypass grafting in-hospital mortality in a Chinese population.

Authors:  Zhe Zheng; Lu Zhang; Xi Li; Shengshou Hu
Journal:  Front Med       Date:  2013-09-18       Impact factor: 4.592

Review 2.  Current situation and challenge of registry in China.

Authors:  Yang Zhang; Yuji Feng; Zhi Qu; Yali Qi; Siyan Zhan
Journal:  Front Med       Date:  2014-09-03       Impact factor: 4.592

3.  Evaluation of accuracy of Euroscore risk model in prediction of perioperative mortality after coronary bypass graft surgery in Isfahan.

Authors:  Mohsen Mirmohammad Sadeghi; Mahfar Arasteh; Mojgan Gharipour; Peyman Nilfroush; Hamid Shamsolketabi; Ali Etesampour; Fatemeh Mirmohammad Sadeghi; Amjad Kiani; Pouya Mirmohammad Sadeghi; Niloufar Farahmand
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

4.  Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.

Authors:  Heng Zhang; Xin Yuan; Haibo Zhang; Sipeng Chen; Yan Zhao; Kun Hua; Chenfei Rao; Wei Wang; Hansong Sun; Shengshou Hu; Zhe Zheng
Journal:  Circulation       Date:  2015-04-23       Impact factor: 29.690

5.  Assessment of three risk evaluation systems for patients aged ≥70 in East China: performance of SinoSCORE, EuroSCORE II and the STS risk evaluation system.

Authors:  Lingtong Shan; Wen Ge; Yiwei Pu; Hong Cheng; Zhengqiang Cang; Xing Zhang; Qifan Li; Anyang Xu; Qi Wang; Chang Gu; Yangyang Zhang
Journal:  PeerJ       Date:  2018-02-23       Impact factor: 2.984

6.  Validation of SinoSCORE for isolated CABG operation in East China.

Authors:  Xiue Ma; Yunqian Wang; Lingtong Shan; Zhengqiang Cang; Chang Gu; Nianyi Qu; Qifan Li; Jun Li; Zhenhua Wang; Yangyang Zhang
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

7.  Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence (MISSION-2).

Authors:  Chong-Yang Liu; Jun-Zhe Du; Chen-Fei Rao; Heng Zhang; Han-Ning Liu; Yan Zhao; Li-Meng Yang; Xi Li; Jing Li; Jue Wang; Hui-Shan Wang; Zhi-Gang Liu; Zhao-Yun Cheng; Zhe Zheng
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

8.  Coronary artery mechanics induces human saphenous vein remodelling via recruitment of adventitial myofibroblast-like cells mediated by Thrombospondin-1.

Authors:  Gloria Garoffolo; Matthijs S Ruiter; Marco Piola; Maura Brioschi; Anita C Thomas; Marco Agrifoglio; Gianluca Polvani; Lorenzo Coppadoro; Stefano Zoli; Claudio Saccu; Gaia Spinetti; Cristina Banfi; Gianfranco B Fiore; Paolo Madeddu; Monica Soncini; Maurizio Pesce
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.